PTPRC and B-cell chronic lymphocytic leukemia: CD38-expressing CLL cells exhibited enhanced CD45 activity, with CD43 and galectin-1 co-expressed alongside CD38, suggesting CD38 may control high CD45 activity in CLL cells.